(Q43181601)

15 November 2017

title

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study (English)

1 reference

15 November 2017

0 references

Craig J Currie

1

1 reference

15 November 2017

John R Peters

2

1 reference

15 November 2017

Aodán Tynan

3

1 reference

15 November 2017

Marc Evans

4

1 reference

15 November 2017

Robert J Heine

5

1 reference

15 November 2017

Oswaldo L Bracco

6

1 reference

15 November 2017

Tony Zagar

7

1 reference

15 November 2017

Chris D Poole

8

1 reference

15 November 2017

language of work or name

English

0 references

publication date

26 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

375

1 reference

15 November 2017

issue

9713

1 reference

15 November 2017

page(s)

481-489

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Validation of information recorded on general practitioner based computerised data resource in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Mortality in people with Type 2 diabetes in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Safety of very tight blood glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Hypoglycemia in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Hypokalaemia during insulin-induced hypoglycaemia in hypopituitary adults with and without growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Acute hyperglycemia and oxidative stress: direct cause and effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Biomarkers of atherosclerotic plaque instability and rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Association between serious ischemic cardiac outcomes and medications used to treat diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Patients with type 2 diabetes undergoing coronary artery bypass graft surgery: predictors of outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Diabetes and mortality following acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

Glycemic control and prevention of microvascular and macrovascular disease in the Steno 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961969-3

7 January 2021

10.1016/S0140-6736(09)61969-3

Identifiers

DOI

1 reference

15 November 2017

1 reference